Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of GB06 human growth hormone injection in children with growth failure due to growth hormone deficiency
CTR20261480Phase 3Active
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Jun 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in growth hormone deficiency (GHD), faltering growth (FTT), sponsored by Sinovac Biotech Ltd.. Started Jun 2026; status: active.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)faltering growth (FTT)
Beyond the preview
Go deeper on CTR20261480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261480.